| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |